Accuray Incorporated ARAY

Company Overview

Accuray Incorporated is a U.S.-based medical technology company focused on radiation oncology solutions for the treatment of cancer and certain neurological conditions. The company develops, manufactures, sells, and supports advanced radiation therapy systems designed to deliver highly precise tumor targeting while minimizing exposure to surrounding healthy tissue. Accuray operates primarily within the medical device and oncology technology industries, with revenue generated through the sale of treatment systems, software, service contracts, upgrades, and related consumables.

The company’s principal product platforms are the CyberKnife robotic radiosurgery system and the Radixact and TomoTherapy radiation therapy systems. These technologies are used by hospitals, cancer centers, and specialty treatment clinics globally. Accuray’s competitive positioning centers on precision treatment delivery, adaptive radiation therapy capabilities, integrated imaging, and robotic motion tracking technologies. Founded in 1990 as a spinout connected to research conducted at Stanford University, the company initially focused on stereotactic radiosurgery innovation before expanding into broader radiation therapy solutions through product development and acquisitions, including the acquisition of TomoTherapy Incorporated in 2011.